Navigation Links
Biopure Receives Notice of Nasdaq Delisting
Date:6/30/2009

CAMBRIDGE, Mass., June 30 /PRNewswire-FirstCall/ -- Biopure Corporation (Nasdaq: BPUR) announced that it has received notice from The Nasdaq Stock Market, by letter dated June 24, 2009, that it is out of compliance with the Nasdaq Marketplace Rules and its common stock may be delisted. The notice stated that the company no longer meets the minimum of $2,500,000 in stockholders' equity for continued listing on the Nasdaq Capital Market.

Nasdaq advised that the company has 15 calendar days to submit a plan to regain compliance. If such plan is accepted, Nasdaq may grant an extension of up to 105 days from the date of notification to regain compliance. If the Company is unable to regain compliance its common stock will be delisted. The company does not intend to submit a plan to regain compliance.

Biopure Corporation

Biopure Corporation develops and markets pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. The company has limited remaining cash. It is exploring the potential sale of some, substantially all, or all of its assets, and is evaluating liquidation. 

    Contact:  Zaf Zafirelis
              Biopure Corporation
              (617) 234-6500
              IR@biopure.com


'/>"/>
SOURCE Biopure Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Biopure Announces Reverse Stock Split
2. Biopures Stock Symbol Reverts to BPUR
3. Biopure Announces Closing of $14.9 Million Financing
4. Four Abstracts by Biopure and Collaborating Scientists Accepted for Annual Meeting of American Society for Clinical Pharmacology and Therapeutics
5. Biopure Announces 2007 Fourth Quarter and Year-End Financial Results
6. Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
7. Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
8. Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
9. Agency Takes Adverse Decision to Biopures Product Registration in South Africa
10. Biopure Sues National Institutes of Health Official
11. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)... Innovative medical apparel company launch... San Clemente, Calif. (PRWEB)...kthrough medical apparel, today announced the laun... Medica 2009, a leading international trade fair f...y. Medelita inaugurates its men,s collection with ...
(Date:11/21/2009)... Linwood Group ask whether there is a secr...ed? , London, UK (PRWEB) ...h up to one in three of the adult UK population dr...ng alcohol-related liver disease*, it is hardly a ...abilitation programmes and residential centres for...
(Date:11/20/2009)...ASHINGTON, Nov. 20 The ... the Senate to make essential changes its health r...n abortion funding and conscience protection on ab...ts and include strong provisions for adequate affo...lth care bill an "enormous disappointment" that cr...
(Date:11/20/2009)...O, Nov. 20 The American...d and Drug Administration (FDA) to establish appro...ls. ,, Citing concern about the safety of whit... the benefit of professional consultation or exami... application of chemically based tooth whitening o...
(Date:11/20/2009)...AS, Nov. 20 The followi...ctor of the Nevada Health Care Association: ,, ...s and thanks Senate Majority Leader Harry Reid for... toward our goal of protecting every Nevada senior...d preserving the strength and viability of our sta...
Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2Health News:Medelita Introduces Men's Lab Coat Collection 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2
...lar disorder respond differently to facial express...according to a new study led by a Bradley Hospital...insight into the neurobiology of pediatric bipolar...isorder in kids, our understanding of its neurobio...
...versity of Pennsylvania School of Medicine and oth...ic stimulation (TMS) a non-invasive technique tha... passed through the scalp is a safe and effective...udy the largest to-date studying TMS as a standal...
...more dense breasts, , , MONDAY, Nov. 26 (H...pear to have more dense breast tissue than their s...ts. , The finding is potentially important because...n the United Kingdom, found that city-dwelling wom...
...king-related, and its there in bright medical imag... in the lungs, caused by secondhand cigarette smok... lung injury to nonsmokers that was long suspected...strict secondhand smoke. , We used a special typ...
...hers have identified structural damage to the lung...sults of the study, conducted by researchers at th...rlottesville and The Childrens Hospital of Philade...hat prolonged exposure to secondhand smoke may cau...
... RN, FAAN, FAHA, a clinical professor of neurology...d an investigator at the Framingham Heart Study, w...the American Heart Association (AHA). The award wa...ely work to integrate stroke and heart disease in ...
Other Medicine News:Health News:Facial expressions have greater impact on kids with bipolar disorder 2Health News:Penn research shows transcranial magnetic stimulation effective in treating major depression 2Health News:Urban Women May Have Greater Breast Cancer Risk 2Health News:Urban Women May Have Greater Breast Cancer Risk 3Health News:Secondhand smoke damages lungs, MRIs show 2Health News:Novel MRI technique shows secondhand smoke damages lungs 2
(Date:11/20/2009)... MINNEAPOLIS, Nov. 20 Bi...ults for its first quarter ended September 30, 200...ted share, on revenues of $3,263,000. This compar...ed share, on revenues of $3,168,000 for the first ...t quarter results, Biotel President and CEO Steve ...
(Date:11/20/2009)..., FRANKLIN LAKES, N.J., Nov. 20 /PRNewswire-FirstC... BDX ) today announced the completion of its acqu...based company that develops and manufactures molec..., In May 2009, BD and HandyLab announced an exc...ze molecular assays on the HandyLab Jaguar(TM) pla...
(Date:11/19/2009)..., ARDEE, Ireland, Nov. 19 Warner ...pricing of its previously announced secondary offe...ce to the public of $22.25 per share. The selling...apital Partners, DLJ Merchant Banking, J.P. Morgan...Lee Partners, L.P., certain other institutional in...
Breaking Medicine Technology:Biotel Announced Profitable First Quarter Ended September 30, 2009 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Warner Chilcott Prices Secondary Equity Offering 2Warner Chilcott Prices Secondary Equity Offering 3Warner Chilcott Prices Secondary Equity Offering 4Lupin Expands Branded Play 5066 1Lupin Expands Branded Play 5066 2Lupin Expands Branded Play 5066 3Sexually satisfied women have better general well being and more vitality 58485 1Sexually satisfied women have better general well being and more vitality 58485 2Sexually satisfied women have better general well being and more vitality 58485 3Is trash the solution to tackling climate change 3F 14282 1
...E) -- MGI PHARMA, INC.,(NASDAQ:MOGN), a biopharmac..., today announced the presentation of results of a...ospropofol,disodium) Injection in patients undergo...dpoint results, as well as safety data, were,prese... D.C. by,Lawrence B. Cohen, MD, Department of Medi...
...ms and Urine Flow, With,Long Lasting Effect in Pha...re-FirstCall/ -- Spectrum,Pharmaceuticals, Inc., t...r ozarelix, the Company,s drug candidate for the t... the American Urology,Association Annual Meeting h...alifornia on Tuesday, May 22, 2007. , "The results...
Other Medicine Technology:Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 2Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 3Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 4Aquavan (Fospropofol Disodium) Injection Data Presented at,Digestive Disease Week 2007 5Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 2Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 3Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 4Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at,Annual Meeting of American Urological Association 5
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
...aboratory and a worldwide leader in innovative lab...xtensive test menu of highly complex and unique me...ned by the University of Utah, ARUP Laboratories' ...versity teaching hospitals and children's hospital...
Medicine Products: